Its anchor trials are SURMOUNT (tirzepatide for weight management, The New England Journal of Medicine , 2022) and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024), alongside STEP for semaglutide (NEJM 2021)
Skin quality and energy shifts are among the most subjectively noticeable outcomes by the end of month two
Your original pharmacy labelshowing your name, medication name, and prescribing physicianserves as the official proof needed at security checkpoints
We use the information we collect for purposes allowed by applicable laws, including to: We may combine the information we collect from you with information that we collect from other sources
First-line investigations typically include serum/urine hCG, FSH, LH, oestradiol, prolactin, and thyroid function tests